Liverpool ChiroChem

Chemical technology innovator that produces chiral small molecules for biotech/pharmaceutical R&D

Liverpool ChiroChem (LCC) specialises in providing chiral small molecules to support biotech and pharmaceutical research and development. Its proprietary PACEā„¢ platform enables faster drug discovery by offering access to a diverse and novel chiral chemical space. LCC supplies essential building blocks, fragments and intermediates for drug discovery, with the capability to produce compounds at scales ranging from milligrams to multi-kilograms.

  • Investment status Current
  • Invested 2015
  • Category Health & Life Sciences